中文摘要：

结外NK／T细胞淋巴瘤（ENKTL）是EB病毒相关、高度侵袭性的非霍奇金淋巴瘤，患者大多分布在亚洲和南美洲地区，晚期患者预后较差。2016年第58届美国血液学会年会关于ENKTL研究进展涵盖从基础研究到临床诊疗多个方面：高通量测序技术对于ENKTL发病机制研究进一步深入，新型预后积分系统的提出有助于更好地区分患者，而新型治疗方案能够进一步提高该类患者的临床疗效和安全性。

英文摘要：

Extranodal natural killer/T cell lymphoma （ENKTL） is an EBV-associated and highly aggressive subtype of non-Hodgkin lymphoma. Most patients are distributed in Asia and South America, and advanced-stage patients have poor prognosis. Reports on research progress of ENKTL in the 58th American Society of Hematology Annual Meeting covered multiple respects which range from basic research to clinical prognosis and treatment： further study on pathogenesis of ENKTL is developing based on high-throughput sequence, and new prognostic index system can help to stratify patients more exactly; what＇s more, novel regimens make more benefits to the clinical efficacy and safety of ENKTL patients.